A coagulation factor IX-deficient mouse model for human hemophilia B

Area of Science:

• Genetics
• Hematology
• Molecular Biology

Background:

• Hemophilia B in humans results from coagulation factor IX deficiency.
• Developing animal models is crucial for understanding and treating genetic bleeding disorders.

Purpose of the Study:

• To develop a genetically engineered mouse model deficient in coagulation factor IX.
• To establish a preclinical tool for hemophilia B research, including gene therapy and protein studies.

Main Methods:

• Gene targeting in mouse embryonic stem (ES) cells using a specific vector to disrupt the factor IX gene.
• Generation of chimeric mice and subsequent breeding to obtain factor IX-knockout offspring.
• Phenotypic characterization of the resulting factor IX-deficient mice.

Main Results:

• Successfully generated a mouse strain with a targeted factor IX gene knockout.
• Transmitted the targeted gene through female offspring to produce affected males.
• Factor IX-deficient male mice exhibited a phenotype consistent with hemophilia B.

Conclusions:

• The developed factor IX-knockout mouse strain serves as an effective model for hemophilia B.
• This model is suitable for in vivo investigations of gene therapy strategies.
• The strain will aid in studying the structure-function relationships of recombinant factor IX proteins.